Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2012 1
2014 4
2015 3
2016 6
2017 2
2018 10
2019 6
2020 4
2021 11
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.
Chari A, Vogl DT, Gavriatopoulou M, Nooka AK, Yee AJ, Huff CA, Moreau P, Dingli D, Cole C, Lonial S, Dimopoulos M, Stewart AK, Richter J, Vij R, Tuchman S, Raab MS, Weisel KC, Delforge M, Cornell RF, Kaminetzky D, Hoffman JE, Costa LJ, Parker TL, Levy M, Schreder M, Meuleman N, Frenzel L, Mohty M, Choquet S, Schiller G, Comenzo RL, Engelhardt M, Illmer T, Vlummens P, Doyen C, Facon T, Karlin L, Perrot A, Podar K, Kauffman MG, Shacham S, Li L, Tang S, Picklesimer C, Saint-Martin JR, Crochiere M, Chang H, Parekh S, Landesman Y, Shah J, Richardson PG, Jagannath S. Chari A, et al. Among authors: yee aj. N Engl J Med. 2019 Aug 22;381(8):727-738. doi: 10.1056/NEJMoa1903455. N Engl J Med. 2019. PMID: 31433920 Clinical Trial.
Myeloma and Bone Disease.
Panaroni C, Yee AJ, Raje NS. Panaroni C, et al. Among authors: yee aj. Curr Osteoporos Rep. 2017 Oct;15(5):483-498. doi: 10.1007/s11914-017-0397-5. Curr Osteoporos Rep. 2017. PMID: 28861842 Review.
A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma.
O'Donnell EK, Laubach JP, Yee AJ, Chen T, Huff CA, Basile FG, Wade PM, Paba-Prada CE, Ghobrial IM, Schlossman RL, Burke JN, Harrington CC, Lively KJ, Lyons HF, Munshi NC, Anderson KC, Trippa L, Richardson PG, Raje NS. O'Donnell EK, et al. Among authors: yee aj. Br J Haematol. 2018 Jul;182(2):222-230. doi: 10.1111/bjh.15261. Epub 2018 May 8. Br J Haematol. 2018. PMID: 29740809 Free PMC article. Clinical Trial.
Lifestyle considerations in multiple myeloma.
Shapiro YN, Peppercorn JM, Yee AJ, Branagan AR, Raje NS, Donnell EKO. Shapiro YN, et al. Among authors: yee aj. Blood Cancer J. 2021 Oct 26;11(10):172. doi: 10.1038/s41408-021-00560-x. Blood Cancer J. 2021. PMID: 34702799 Free PMC article. Review.
How We Approach Smoldering Multiple Myeloma.
Raje N, Yee AJ. Raje N, et al. Among authors: yee aj. J Clin Oncol. 2020 Apr 10;38(11):1119-1125. doi: 10.1200/JCO.19.02834. Epub 2020 Jan 31. J Clin Oncol. 2020. PMID: 32004107 Free PMC article.
Panobinostat and Multiple Myeloma in 2018.
Yee AJ, Raje NS. Yee AJ, et al. Oncologist. 2018 May;23(5):516-517. doi: 10.1634/theoncologist.2017-0644. Epub 2018 Feb 14. Oncologist. 2018. PMID: 29445026 Free PMC article.
Advances in supportive care for multiple myeloma.
Raje NS, Yee AJ, Roodman GD. Raje NS, et al. Among authors: yee aj. J Natl Compr Canc Netw. 2014 Apr;12(4):502-11. doi: 10.6004/jnccn.2014.0055. J Natl Compr Canc Netw. 2014. PMID: 24717569 Review.
47 results